Are Stanrose Mafatlal Investment & Finance Ltd latest results good or bad?

May 19 2026 07:17 PM IST
share
Share Via
Stanrose Mafatlal Investment & Finance Ltd's latest results for Q4 FY26 show significant revenue growth of 156.72% to ₹1.72 crores, but the company continues to face operational challenges with a persistent net loss of ₹0.89 crores and negative margins, raising concerns about its long-term viability and sustainability.
The latest financial results for Stanrose Mafatlal Investment & Finance Ltd for Q4 FY26 reveal a complex picture of operational challenges. The company reported net sales of ₹1.72 crores, reflecting a significant quarter-on-quarter growth of 156.72% from ₹0.67 crores in Q3 FY26. However, this revenue increase appears to stem from sporadic income generation rather than a sustainable business model, as evidenced by the persistent net loss of ₹0.89 crores, which remained unchanged from the same quarter last year.
The operating profit before depreciation, interest, and tax (PBDIT) was deeply negative at ₹0.70 crores, translating to an operating margin of -40.70%. This consistent negative operating margin highlights the company's ongoing struggle to generate positive cash flows from its core operations. The company's profitability metrics, including a negative PAT margin of -51.74%, further underscore the operational inefficiencies that have plagued it for several quarters. In terms of balance sheet health, shareholder funds have declined to ₹41.46 crores from ₹47.94 crores a year earlier, driven by accumulated losses. The company's asset composition indicates limited operational infrastructure, with fixed assets at just ₹0.77 crores and a significant portion of its asset base tied up in investments and current assets. Despite maintaining a debt-free balance sheet, the company faces significant concerns regarding its long-term viability. The persistent losses over seven consecutive quarters, totaling ₹3.03 crores for FY26, raise serious questions about its operational sustainability without substantial restructuring or capital infusion. The company has seen an adjustment in its evaluation, reflecting the market's concerns about its ability to generate sustainable profits and the ongoing erosion of shareholder value. Overall, Stanrose Mafatlal's financial results indicate a company grappling with fundamental operational challenges, necessitating a critical reassessment of its business model and strategy moving forward.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News